title

 

Publications with acknowledgement to BIO-DrIM

 

Viklicky O, Krystufkova E, Brabcova I, Sekerkova A, Wohlfahrt P, Hribova P, Wohlfahrtova M, Sawitzki B,
Slatinska J, Striz I, Volk H.D and Reinke P
B-Cell-Related Biomarkers of Tolerance are Up-Regulated in Rejection-Free Kidney Transplant Recipients.
Transplantation 2013, 95(1), 148-54. doi: 10.1097/TP.0b013e3182789a24.

Viklicky O, Hribova P, Brabcova I
Molecular markers of rejection and tolerance: lessons from clinical research.
Nephrol Dial Transplantation 2013, 28(11), 2701-08. doi: 10.1093/ndt/gft102.

Schachtner T, Stein M, Sefrin A, Babel N, Reinke P
Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.
Transpl Int 2014, 27(3), 290-301. doi:10.1111/tri.12251.

Baid-Agrawal S, Schindler R, Reinke P, Staedtler A, Rimpler S, Malik B, Frei U, Berg T
Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients.
J Hepatol 2014, 60(5), 928-33. doi:10.1016/j.jhep.2014.01.012.

Juvet SC, Whatcott AG, Bushell AR, Wood KJ
Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.
Am J Transplant 2014, 14(4), 750-63. doi: 10.1111/ajt.12647.

Wohlfahrtova M, Viklicky O
Recent trials in immunosuppression and their consequences for current therapy.
Curr Opin Organ Transplant 2014, 19(4), 387-94. doi: 10.1097/MOT.0000000000000093.

Lúcia M, Crespo E, Cruzado JM, Grinyó JM, Bestard O
Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigm.
Transpl Int. 2014, 27(7), 643-56. doi: 10.1111/tri.12318.

Stolp J, Turka LA, Wood KJ
B cells with immune-regulating function in transplantation.
Nat Rev Nephrol 2014, 10(7), 389-97. doi: 10.1038/nrneph.2014.80.

Girmanova E, Hruba P, Viklicky O
Circulating biomarkers of tolerance.
Transplant Rev (Orlando) 2015, 29(2), 68-72. doi: 10.1016/j.trre.2015.01.003.

Volk HD, Stevens MM, Mooney DJ, Grainger DW, Duda GN
Key elements for nourishing the translational research environment.
Sci Transl Med 2015, 7(282), 282cm2. doi: 10.1126/scitranslmed.aaa2049.

Schmueck-Henneresse M, Sharaf R, Vogt K, Weist BJ, Landwehr-Kenzel S, Führer H, Jurisch, A, Babel N, Rooney CM, Reinke P, Volk HD
Peripheral blood-derived virus-specific memory stem Tcells mature to functional effector memory subsets with self-renewal potency.
J. Immunol 2015, 194 (11), 5559-67. doi: 10.4049/jimmunol.1402090.

Weist BJ, Wehler P, El Ahmad L, Schmueck-Henneresse M, Millward JM, Nienen M, Neumann AU, Reinke P, Babel N
A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.
Kidney Int 2015, 88(6), 1293-1303. doi:10.1038/ki.2015.215.

Braza, F, Dugast E, Panov I, Paul C, Vogt K, Pallier A, Chesneau M, Baron D, Guerif P, Lei H, Laplaud DA, Volk HD,
Degauque N, Soulillou JP, Sawitzki B, Brouard S
Central role of CD45RA-Fox3hi memory regulatory T cells in Clinical kidney transplantation tolerance.
J Am Soc Nephrol 2015, 26(8), 1795-805. doi: 10.1681/ASN.2014050480.

Schachtner T, Babel N, Reinke P
Different risk factor profiles distinguish early-onset from late-onset BKV-replication.
Transpl Int 2015, 28(9), 1081-91. doi: 10.1111/tri.12601.

Asadullah K, Busch A, Gottwald M, Reinke P, Landeck L
Industry-academia collaborations for biomarkers.
Nat Rev Drug Discov. 2015, 14(12), 805-6. doi: 10.1038/nrd4727.

Wohlfahrtova M, Tycova I, Honsova E, Lodererova A, Viklicky O
Molecular patterns of subclinical and clinical rejection of kidney allograft: quantity matters.
Kidney Blood Press Res 2015, 40(3), 244-257. doi: 10.1159/000368500.

Wohlfahrtova M, Viklicky O
New strategies for evaluating the quality of kidney grafts from elderly donors.
Transplant Rev (Orlando) 2015, 29(4), 212-8. doi: 10.1016/j.trre.2015.04.002.

Hruba P, Brabcova I, Gueler F, Krejcik Z, Stranecky V, Svobodova E, Maluskova J, Gwinner W, Honsova E,
Lodererova A, Oberbauer R, Zachoval R, Viklicky O
Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes.
Kidney Int. 2015, 88(4), 785-95. doi: 10.1038/ki.2015.211.

Krepsova E, Tycova I, Sekerkova A, Wohlfahrt P, Hruba P, Striz I, Sawitzki B, Viklicky O  
Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance.
BMC Nephrol. 2015, 16, 146. doi: 10.1186/s12882-015-0141-2.

Schlickeiser S, Streitz M, Sawitzki B
Standardized Multi-Color Flow Cytometry and Computational Biomarker Discovery.
Methods Mol Biol 2016, 1371, 225-38. doi: 10.1007/978-1-4939-3139-2_15.

Weber SA, Pietzsch M, Bestard O, Reinke P, Grinyo JM
Investigating the Health-economic Profiles of Biomarker-Driven Immunosuppression (BioDrIM) Following Solid Organ Transplantation.
Value Health 2015, 18(7), A534. doi: 10.1016/j.jval.2015.09.1669.